Skip to main content
Premium Trial:

Request an Annual Quote

Diaceutics, London Genetics to Co-Develop Software to Support Biomarker Research Collaborations

Premium

Personalized medicine consultancy Diaceutics is partnering with pharmacogenomics service provider London Genetics to develop software tools that will help biopharmaceutical companies access data and samples from academic biomarker research groups, the companies said today.

The new software, which the firms plan to launch next year, is based on the Diaceutics Fusion platform, a personalized medicine planning application designed for targeted therapy development teams, and the London Genetics Biomarker Pathway platform.

The companies said that the new software will allow research teams to build biomarker hypotheses, request expressions of interest for patient samples, and prepare proposals for clinical development.

Expressions of interest for access to patient samples will be sent to academic biomarker research teams, including London Genetics’ network of more than 3,000 investigators.

"The new tools will enable commercial biomarker research teams to comprehensively explore global biomarker resources to identify genes and gene sequences, as well as the researchers and clinicians relevant to their targeted therapy research," the companies said.

“Biomarker research is often limited because teams don’t know the capabilities of external research centers and miss potential collaborations which could accelerate their targeted therapy development,” Peter Keeling, CEO of Diaceutics, said in a statement.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.